226 related articles for article (PubMed ID: 15200043)
41. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival.
Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH
Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423
[TBL] [Abstract][Full Text] [Related]
42. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.
Shindo M; Wu JC; Park EE; Tanzella F
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):650-4. PubMed ID: 16785411
[TBL] [Abstract][Full Text] [Related]
43. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
44. Extent of thyroidectomy and lymphadenectomy in 254 patients with papillary thyroid microcarcinoma: a single-institution experience.
Besic N; Zgajnar J; Hocevar M; Petric R
Ann Surg Oncol; 2009 Apr; 16(4):920-8. PubMed ID: 19189188
[TBL] [Abstract][Full Text] [Related]
45. [One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma].
Pan YF; Zhang XH; Ye GH; Lin BR; Chen XM; Jia XJ; Zhou SM; Wang OC
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):389-92. PubMed ID: 17045009
[TBL] [Abstract][Full Text] [Related]
46. Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes.
Wang TS; Dubner S; Sznyter LA; Heller KS
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):110-3. PubMed ID: 14732779
[TBL] [Abstract][Full Text] [Related]
47. [Surgery of differentiated cancer of the thyroid].
De Antoni E; Catania A; Biancari F; Di Matteo FM; Falvo L; Grilli P; Lippolis G; Sorrenti S; Spyrou M; Dibra A; D'Andrea V; Redler A
G Chir; 1997 Oct; 18(10):525-31. PubMed ID: 9479956
[TBL] [Abstract][Full Text] [Related]
48. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
Seaberg RM; Eski S; Freeman JL
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
[TBL] [Abstract][Full Text] [Related]
49. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
50. Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma.
Zuniga S; Sanabria A
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1087-91. PubMed ID: 19917919
[TBL] [Abstract][Full Text] [Related]
51. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
Yildirim E
J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
[TBL] [Abstract][Full Text] [Related]
52. Treatment of thyroid cancer based on risk groups.
Shaha A
J Surg Oncol; 2006 Dec; 94(8):683-91. PubMed ID: 17131422
[TBL] [Abstract][Full Text] [Related]
53. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer.
Haigh PI; Urbach DR; Rotstein LE
Ann Surg Oncol; 2005 Jan; 12(1):81-9. PubMed ID: 15827782
[TBL] [Abstract][Full Text] [Related]
54. Follicular thyroid carcinoma: histology and prognosis.
D'Avanzo A; Treseler P; Ituarte PH; Wong M; Streja L; Greenspan FS; Siperstein AE; Duh QY; Clark OH
Cancer; 2004 Mar; 100(6):1123-9. PubMed ID: 15022277
[TBL] [Abstract][Full Text] [Related]
55. Thyroid carcinoma: results from surgical treatment in 211 consecutive patients.
Salvesen H; Njølstad PR; Akslen LA; Albrektsen G; Viste A; Søreide O; Varhaug JE
Eur J Surg; 1991 Sep; 157(9):521-6. PubMed ID: 1683575
[TBL] [Abstract][Full Text] [Related]
56. Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype.
Falvo L; D'Ercole C; Sorrenti S; D'Andrea V; Catania A; Berni A; Grilli P; De Antoni E
Eur J Surg Suppl; 2003 Jul; (588):28-32. PubMed ID: 15200040
[TBL] [Abstract][Full Text] [Related]
57. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
58. Clinical predictors of quality of life in patients with initial differentiated thyroid cancers.
Almeida JP; Vartanian JG; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):342-6. PubMed ID: 19380354
[TBL] [Abstract][Full Text] [Related]
59. Surgical treatment of differentiated microcarcinomas of the thyroid.
Ruggieri M; Genderini M; Gargiulo P; Del Grammastro A; Mascaro A; Luongo B; Paolini A
Eur Rev Med Pharmacol Sci; 2001; 5(3):85-9. PubMed ID: 12004917
[TBL] [Abstract][Full Text] [Related]
60. High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts.
Hartl DM; Al Ghuzlan A; Chami L; Leboulleux S; Schlumberger M; Travagli JP
Ann Surg Oncol; 2009 Sep; 16(9):2595-601. PubMed ID: 19565286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
